The nation of Zimbabwe has turned down a major American healthcare agreement worth $367m (272 million pounds) spanning five years over the United States' insistence on confidential biological samples.
The decision came to light after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since stated that the US was demanding access to health data for research and profit while was not willing to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement agreeable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Implications
This development follows a similar case in neighbouring Kenya, where a high court halted a related health funding agreement following concerns were filed about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no certainty that the final treatments would be accessible to our people if a new disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously set up via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future co-operation could be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Response
A leading public health body stated it acknowledged the official position, but suggested that negotiations should continue given that a large portion of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it added.
The halted deal highlights the complex tensions between accepting crucial international aid and protecting national sovereignty in an increasingly data-driven world.